Actively Recruiting
Avalanche Phenomenon During Airways Opening in Acute Respiratory Distress Syndrome
Led by Poitiers University Hospital · Updated on 2025-12-24
50
Participants Needed
1
Research Sites
239 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Acute respiratory distress syndrome accounts for 23% of mechanically ventilated patients and is associated with high mortality rate. Although life-saving, mechanical ventilation may worsen lung injury through two main mechanisms: lung overdistension and atelectrauma. Indeed, the cyclic opening and closure of airways during tidal ventilation may cause lung and bronchial injuries as suggested by animal models and autopsy findings. Complete airways closure has recently been described in 40% of patients with acute respiratory distress syndrome, and setting positive end-expiratory pressure above the airway opening pressure may limit atelectrauma. However, animal and mathematical models suggest that above the airway opening pressure, more distal airways open unevenly according to their own opening pressure, resulting in an "avalanche"-like phenomenon during lung inflation. This phenomenon has never been described in humans. A better understanding of the opening of airways in acute respiratory distress syndrome may help to limit ventilation-induced lung injury and to improve outcomes.
CONDITIONS
Official Title
Avalanche Phenomenon During Airways Opening in Acute Respiratory Distress Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age �318 years
- Moderate-to-severe acute respiratory distress syndrome within the first 72 hours after meeting the Berlin definition criteria
- Within 1 week of a known clinical insult or new or worsening respiratory symptoms
- Bilateral opacities not fully explained by effusions, lobar/lung collapse, or nodules
- Respiratory failure not fully explained by cardiac failure or fluid overload
- PaO2/FiO2 �3200 mmHg with positive end-expiratory pressure �35 cmH2O
- Absence of spontaneous breathing efforts
- Consent to participate to the study from the patient and/or its surrogate
You will not qualify if you...
- Pneumothorax
- Broncho-pleural fistula
- Tracheostomy
- Hemodynamic instability
- Severe hypoxemia
- Suspected or proven intracranial hypertension
- Chronic obstructive lung disease
- Pacemaker or defibrillator
- Decision to withhold or withdraw life-sustaining measures
- Under protection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU Poitiers
Poitiers, France, 86000
Actively Recruiting
Research Team
R
Rémi Coudroy, MD, PhD
CONTACT
C
Céline DELETAGE
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here